Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial
- 17 May 2000
- journal article
- clinical trial
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 15 (5) , 387-392
- https://doi.org/10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodiesThe British Journal of Psychiatry, 1999
- Dementia with Lewy bodiesNeurology, 1998
- Metrifonate treatment of the cognitive deficits of Alzheimer's diseaseNeurology, 1998
- Cholinesterase inhibition in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Neuroleptic sensitivity to risperidone in Lewy body dementiaThe Lancet, 1995
- The Neuropsychiatric InventoryNeurology, 1994
- Lewy bodies and response to tacrine in Alzheimer's diseaseThe Lancet, 1994
- Physostigmine ameliorates the delusions of Alzheimer's diseaseBiological Psychiatry, 1993
- Neuroleptic sensitivity in patients with senile dementia of Lewy body type.BMJ, 1992
- “Mini-mental state”Journal of Psychiatric Research, 1975